Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors

By  

Current Cancer Therapy Reviews, Vol. 6, Iss. 1, 2010-02 ,pp. : 51-61

Bentham Science Publishers

Access to resources Recommend Favorite

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

By Jonat Walter   Hilpert Felix  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 6, 2006-06 ,pp. : 343-355

Springer Publishing Company

Access to resources Recommend Favorite

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

By Jonat Walter   Hilpert Felix   Maass Nicolai  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 32-38

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients

By Markovitch O.   Tepper R.   Fishman A.   Aviram R.   Cohen I.  

Breast Cancer Research and Treatment, Vol. 101, Iss. 2, 2007-01 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase Inhibitors: Indications for Breast Cancer Therapy

By Assikis V.J.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 93-100

Adis International

Access to resources Recommend Favorite